Influenza Drugs: Neuraminidase Inhibitors (Nursing)

by Rhonda Lawes, PhD, RN

My Notes
  • Required.
Save Cancel
    Learning Material 3
    • PDF
      Slides Nursing Pharmacology Antiviral Medications Influenza.pdf
    • PDF
      Reference List Pharmacology Nursing.pdf
    • PDF
      Download Lecture Overview
    Report mistake

    00:00 So let's look at these three compared to each other, now we can give them in multiple different routes, We talked about the inhaled powder route for the Zanamivir, But remember it can be given multiple different routes too.

    00:12 But we focused on the oral route the inhaled powder and an example of an IV route of medication.

    00:18 You've got a difference in minimum of age.

    00:21 So let's play with that column a little bit when I'm studying a chart like this either kind of questions I ask myself.

    00:26 Why would I give a oseltamivir over one of the other two, well if my patient was what? Three years old, that would be the only option for me.

    00:39 So by asking yourself questions or if you're really good study buddy having them asking you questions.

    00:44 That's a really effective way to learn.

    00:47 Look at the side effects.

    00:48 Look for things that are similar and things that are different.

    00:51 So we know we've got some GI issues kind of over the whole, across the board, right, but we're going to be really careful with inhaled powder and anyone with known lung problems.

    01:01 Now the rare adverse effects, line, right, up.

    01:05 So this is a really easy way great cheat sheet we have for you here.

    01:09 Once you've walked through the other parts of the video before this chart.

    01:13 This one can be really helpful because you've already done the work to think through these things.

    01:18 We just gave you a summary chart here towards the end.

    01:22 Now I want to talk about LAIV.

    01:25 That means Live Attenuated Influenza Virus, so these these drugs Neuraminidase Inhibitors can may blunt the response a patient would have to a live attenuated influenza virus.

    01:38 So we're going to stop these medications.

    01:40 I have full two days before the influenza vaccine.

    01:44 Okay, you want to wait two weeks after the vaccine before you would start these.

    01:48 Also this is really important that you ask if the patient is taken one of these medications before they receive an LAIV.

    01:57 So great task question wouldn't it? Which of the questions? His most important to ask a patient before giving them.

    02:04 This might be an option.

    02:05 So keep that in mind.

    02:07 If a patient is going to receive a live attenuated influenza virus.

    02:11 They shouldn't have taken a Neuraminidise Inhibitor or an NI for a full two days before they get the vaccine.

    02:19 Now what's cool about this? Hey, that's that 48 hour window.

    02:23 So we know start them within 48 Hours of symptoms start prophylaxis within 48 Hours of exposure.

    02:30 Really 12 hours was better but 48 is the limit for that and if they're going to get live attenuated virus, then we want to make sure that they stop and ice two days before getting them.

    02:41 You've got it.

    02:42 I remember wait two weeks, There's the number two again after vaccine to take the medication again.

    About the Lecture

    The lecture Influenza Drugs: Neuraminidase Inhibitors (Nursing) by Rhonda Lawes, PhD, RN is from the course Antiviral Medications (Nursing).

    Included Quiz Questions

    1. It can induce severe hypersensitivity reactions.
    2. It can induce neuropsychiatric effects.
    3. It can be injected subcutaneously.
    4. It should be used for asthma.
    5. COPD patients could benefit from Zanamivir.

    Author of lecture Influenza Drugs: Neuraminidase Inhibitors (Nursing)

     Rhonda Lawes, PhD, RN

    Rhonda Lawes, PhD, RN

    Customer reviews

    5,0 of 5 stars
    5 Stars
    4 Stars
    3 Stars
    2 Stars
    1  Star